Brazil and Mexico account to almost 70% of whole Latin American pharmaceutical Market. Globally, these two markets are ranked 6th and the 12th largest markets in terms of sales. But unlike a lot of other emerging markets these countries are known for complex regulatory structure and high entry barriers. Our local infrastructure and expertise on technical front has made us a trusted name in the industry.
Driven by the mission of serving people with value added healthcare products, Maypharm is dedicated to introduce new products to these two potential markets through local presence.
Maypharm has a subisidiary company in Brazil, supported by an experienced team of Regulatory professionals. Through deep local network and long term collaborations, Maypharm is well equipped to register, import and commercialize pharmaceutical products these high growth markets. Starting from the first step of market intelligence to distribution of products is taken care by us through our local team and partner companies. We are dedicated to serve the local population with technology driven, value added products sourced globally.
Our Local presence and elaborate commercial network, helps us gain valuable insights into pricing, competitive landscape and distribution channels to achieve maximum penetration.
Both these markets have very specific legislative & regulatory requirements at every step in product life cycle. Maypharm has developed adequate infrastructure to fulfill all the requirements at every stage
Maypharm has a highly skilled regulatory team which operates from Brazil & Mexico fully supported by a technical & project management team operating from India.
Through a robust network of Partner companies and local distributors, Maypharm is well equipped to commercilize products in the hospital & retail space in both markets.
Business Model
We believe in the power of collaborations and work on flexible models with technology and manufacturing companies for extending their products to Brazil & Mexico. We prefer to invest fully or partly in the product and assume complete responsibility of Project management, Regulatory, Business Development and Distribution of the product. We are commited to achieve optimum penetration in the market through the network cultivated by us over the years. Currently we are working on a portfolio of almost 30 products for Brazil and 20 products for Mexico. .
Maypharm has a focused portfolio in the following Categories-
| Focus Areas | Specialty Hospital products | Retail Medicinal Products | Wellness Products |
| ANVISA/COFEPRIS Classification Category | · Medicine
· Especifico |
· Medicine
· Herbal Medicine · Especifico |
· Food Supplements
· Herbal Remedy · Notification Products |
| Therapy | · Pain Management
· Antibiotics |
· Pain Management
· Gastrointestinal |
· Immunity
· Pre-Probiotics · General Wellness |
| Dosage Forms | · Infusions
· Lyo Injectables |
· Oral Thin Films
· Effervescent Tablets · Powder Sachets · Patches |
· Oral Thin Films
· Oral Sprays · Oral Drops · Patches |
Please connect with us for further information of the products we are working on.